Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
DE.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DE.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DE.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DE.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.333ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.333ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.333ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.333NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CM.6.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CM.6.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.20NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.34.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.34.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.34.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.34.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JD.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JD.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JD.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JD.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.25ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.25ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.25NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.79ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.79ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.79ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.79NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HP.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HP.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HP.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HP.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FU.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FU.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FU.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FU.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.3.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used